These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Efficacy and safety of oral paliperidone extended-release tablets in the treatment of acute schizophrenia: pooled data from three 52-week open-label studies. Emsley R, Berwaerts J, Eerdekens M, Kramer M, Lane R, Lim P, Hough D, Palumbo J. Int Clin Psychopharmacol; 2008 Nov; 23(6):343-56. PubMed ID: 18854723 [Abstract] [Full Text] [Related]
15. A randomized, double-blind study of paliperidone extended-release in treatment of acute schizophrenia in adolescents. Singh J, Robb A, Vijapurkar U, Nuamah I, Hough D. Biol Psychiatry; 2011 Dec 15; 70(12):1179-87. PubMed ID: 21831359 [Abstract] [Full Text] [Related]
17. Efficacy and safety of paliperidone extended-release in schizophrenia patients with prominent affective symptoms. Canuso CM, Turkoz I, Sheehan JJ, Bossie CA. J Affect Disord; 2010 Jan 15; 120(1-3):193-9. PubMed ID: 19552963 [Abstract] [Full Text] [Related]
18. Paliperidone extended-release for schizophrenia: effects on symptoms and functioning in acutely ill patients with negative symptoms. Canuso CM, Bossie CA, Turkoz I, Alphs L. Schizophr Res; 2009 Aug 15; 113(1):56-64. PubMed ID: 19560322 [Abstract] [Full Text] [Related]